Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

British Journal of Cancer

Volumn 109, Issue 9, 2013, Pages 2316-2322

  Szkandera, J ^a   Gerger, A ^a   Liegl Atzwanger, B ^a   Absenger, G ^a   Stotz, M ^a   Samonigg, H ^a   Maurer Ertl, W ^a   Stojakovic, T ^a   Ploner, F ^a   Leithner, A ^a   Pichler, M ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

C reactive protein; inflammation; prognosis; soft tissue sarcoma

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER SPECIFIC SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK; SOFT TISSUE SARCOMA;

EID: 84887024431     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.595     Document Type: Article

References (35)

1. Absenger G, Szkandera J, Pichler M, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A (2013) A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer 109(2): 395-400.
2. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow?. Lancet 357: 539-545.
3. Claus DR, Siegel J, Petras K, Osmand AP, Gewurz H (1977) Interactions of C-reactive protein with the first component of human complement. J Immunol 119: 187-192.
4. Coindre JM (2006) Grading of soft tissue sarcomas: Review and update. Arch Pathol Lab Med 130: 1448-1453.
5. Cormier JN, Pollock RE (2004) Soft tissue sarcomas. CA Cancer J Clin 54: 94-109.
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867.
7. Crozier JE, McKee RF, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McMillan DC (2007) Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg 94: 1028-1032.
8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) Soft tissue sarcoma. In: AJCC Cancer Staging Manual. 7th edn pp 291-296. Springer: New York, NY, USA.
9. Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO Classification of Tumours of Soft Tissue and Bone. In WHO Classification of Tumours. 4th edn, Vol. 5IARC Press: Lyon, France.
10. Gagnon B, Abrahamowicz M, Xiao Y, Beauchamp ME, MacDonald N, Kasymjanova G, Kreisman H, Small D (2010) Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced nonsmall cell lung cancer. Br J Cancer 102: 1113-1122.
11. Gockel I, Dirksen K, Messow CM, Junginger T (2006) Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-Term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 12: 3746-3750.
12. Groblewska M, Mroczko B, Wereszczyńska-Siemiatkowska U, Kedra B, Lukaszewicz M, Baniukiewicz A, Szmitkowski M (2008) Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin Chem Lab Med 46: 1423-1428.
13. Hara M, Matsuzaki Y, Shimuzu T, Tomita M, Ayabe T, Enomoto Y, Onitsuka T (2007) Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 27: 3001-3004.
14. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K, Takenaka K (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103: 1856-1864.
15. Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C, Tempfer CB, Reinthaller A (2008) Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 14: 710-714.
16. Heikkilä K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61: 824-833.
17. Kattan MW, Leung DH, Brennan MF (2002) Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20: 791-796.
18. Lamb GW, McMillan DC, Ramsey S, Aitchison M (2006) The relationship between the preoperative systemic inflammatory response and cancerspecific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer 94: 781-784.
19. Liegl-Atzwanger B, Hofmann G, Leithner A, Beham A (2009) Undifferentiated high-grade pleomorphic sarcoma (UHPS): Diagnostic criteria, differential diagnosis, and treatment. An attempt to erasure the misnomer MFH. Eur Surg 41: 143-149.
20. Macintyre SS, Schultz D, Kushner I (1982) Biosynthesis of C-reactive protein. Ann NY Acad Sci 389: 76-87.
21. Nakamura T, Grimer R, Gaston C, Francis M, Charman J, Graunt P, Uchida A, Sudo A, Jeys L (2013) The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma. Eur J Cancer 49: 377-385.
22. Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A (2012) Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Cancer 118: 1055-1061.
23. Nakanishi H, Araki N, Kudawara I, Kuratsu S, Matsumine A, Mano M, Naka N, Myoui A, Ueda T, Yoshikawa H (2002) Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma. Int J Cancer 99: 167-170.
24. Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K (2003) Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Lett 192: 89-95.
25. Pichler M, Hutterer GC, Stoeckigt C, Chromecki TF, Stojakovic T, Golbeck S, Eberhard K, Gerger A, Mannweiler S, Pummer K, Zigeuner R (2013) Validation of the pre-Treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 108: 901-907.
26. Ramsey S, Lamb GW, Aitchison M, McMillan DC (2006) The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Br J Cancer 95: 1076-1080.
27. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
28. Rota S, Yildirim B, Kaleli B, Aybek H, Duman K, Kaptanoǧlu B (2005) C-reactive protein levels in non-obese pregnant women with gestational diabetes. Tohoku J Exp Med 206: 341-345.
29. Rutkowski P, Kaminska J, Kowalska M, Ruka W, Steffen J (2002) Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinicopathological features and prognosis. Int J Cancer 100: 463-471.
30. Stefanovski PD, Bidoli E, De Paoli A, Buonadonna A, Boz G, Libra M, Morassut S, Rossi C, Carbone A, Frustaci S (2002) Prognostic factors in soft tissue sarcomas: A study of 395 patients. Eur J Surg Oncol 28: 153-164.
31. Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF (2002) Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas. Ann Surg 235: 424-434.
32. Volanakis JE (2001) Human C-reactive protein: Expression, structure, and function. Mol Immunol 38: 189-197.
33. Weinhold B, Rüther U (1997) Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 327: 425-429.
34. Wigmore SJ, Fearon KC, Sangster K, Maingay JP, Garden OJ, Ross JA (2002) Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 21: 881-886.
35. Zhang D, Jiang SL, Rzewnicki D, Samols D, Kushner I (1995) The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Biochem J 310: 143-148.